Tuberculosis Vaccine

BCG vaccine elevates protective cytokine release

Published in TB and Outbreaks Week, March 12th, 2002

by Michael Greer, senior medical writer - The venerable and widely used Mycobacterium bovis Bacillus Calmette Guerin (BCG) tuberculosis vaccination raises protective cytokine output from immune cells, researchers in the United States report.

Dr. Amminikutty Jeevan and colleagues at the Texas A&M University System Health Science Center in College Station, Texas, and the National Cancer Institute in Frederick, Maryland, investigated the molecular effects of the BCG vaccine in animals.

The vaccine significantly heightens levels of cytokines linked to productive immune activity, Jeevan and coworkers found.

The researchers...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-03-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry